The National Organization for Rare Disorders (NORD®) has announced this year’s roster of rare disease change-makers, the 2020 Rare Impact Award honorees. These exceptional individuals, organizations and industry innovators will be honored for their outstanding work for the rare disease community on May 15, 2020, at the Rock and Roll Hall of Fame in Cleveland, Ohio.
Congratulations go out to the 2020 Industry Innovation Award honorees including, Alnylam Pharmaceuticals, for Givlaari™.
This event is hosted by NORD, one the leading independent advocacy organization dedicated to improving the lives of patients and families impacted by rare diseases.